Pro943 polypeptides

Details Pro943 polypeptides Pro943 polypeptides

2006-07-11

2006-07-11

Murphy, Joseph (Department: 1646)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

C530S300000

Reexamination Certificate

active

07074897

ABSTRACT:
The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

REFERENCES:
patent: 6242419 (2001-06-01), Strachan et al.
Wiedemann M., Trueb B.; “Characterization of a novel protein (FGFRL1) from human cartilage □□RT related to FGF receptors.”; Genomics 69:275-279(2000).
Yan et al., Two-amino acid molecular switch in an epithelial morphogen that regulates binding to two distinct receptors. Science 290:523-527, 2000.
Mickle JE et al. Genotype-phenotype relationships in cystic fibrosis. Med Clin North Am. May 2000; 84(3):597-607.
Voet et al. Biochemistry. 1990. John Wiley & Sons, Inc. pp. 126-128 and 228-234.
GenBank, Accession No.: P—AAF44130, WO 200073454-A1, Pub Date: Dec. 7, 2000, Ashkenazi, A.J. et al.
GenBank, Accession No.: P—AAZ64984, WO 9963088-A2, Pub Date: Dec. 9, 1999, Baker, K. et al.
GenBank, Accession No.: P—AAC58376, WO 200053755-A2, Pub Date: Sep. 14, 2000, Ashkenazi, A.J. et al.
GenBank, Accession No.: AX191426, WO 0149715-A1, Pub Date: Jul. 12, 2001, Ashkenazi, A.J. et al.
GenBank, Accession No.: AX080803, WO 0109327-A, Pub Date: Feb. 8, 2001, Ashkenazi, A.J. et al.
Dayhoff, Accession No.: AAK15273.1, Direct Submission, Submitted: Oct. 11, 2000, Aggarwal, S. et al.
Dayhoff, Accession No.: P—AAB66264, WO 200100673-A1, Pub Date: Jan. 4, 2001, Barnes, T.M. et al.
Dayhoff, Accession No.: P—AAB65179, WO 200073454-A1, Pub Date: Dec. 7, 2000, Ashkenazi, A.J. et al.
Dayhoff, Accession No.: P—AAY66656, WO 9963088-A2, Pub Date: Dec. 9, 1999, Baker K. et al.
Dayhoff, Accession No.: P—AAB24066, WO 200053755-A2, Pub Date: Sep. 14, 2000, Ashkenazi, A.J. et al.
Dayhoff, Accession No.: CAC14171.1,, Direct Submission, Submitted: Apr. 4, 2000, Trueb, B.
Dayhoff, Accession No.: AAK26742.1 Direct Submission, Submitted: Jun. 19, 2000, Kim, I. et al.
Dayhoff, Accession No.: NP—068742.1, Genomics, 69 (2), pp. 275-279, 2000, Wiedemann, M. et al.
Dayhoff, Accession No.: P—AAY92864, WO 200024756-A1, Pub Date: May 4, 2000, Ruben, S.M. et al.
Dayhoff, Accession No.: P—AAM38643, WO 200153312-A1, Pub Date: Jul. 26, 2001, Tang, Y.T. et al.
Hanna, J.S., et al., “HER-2
eu Breat Cancer Predictive Testing”, Oathology Associates Medical Laboratores, Aug. (1999).
Hyman, Elizabeth, et al., “Impact of DNA Amplification on Gene Expression Patterns in Breast Cancer1,2”,Cancer Research62 6240-6245, Nov. (2002).
Orntoft, Torben F., et al., “Genome-wide Study of Gene Copy Numbers, Transcripts, and Protein Levels in Pairs of Non-Invasive and Invasive Human Transitional Cell Carcinomas”,Molecular&Cellular Proteomics1:37-45, (2002).
Pollack, Jonathan R., et al., “Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors”,PNASvol. 99, 20:12963-12968, Oct. (2002).

Affiliated with

Also associated with

Rating

Pro943 polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pro943 polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pro943 polypeptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3575690